Mediwound Ltdis A Biopharmaceutical Company Based In Yavneisraeland Is Publicly Traded On The Nasdaq Under The Ticker Mdwdfounded In 2000The Company Specializes In Developing And Commercializing Bio Therapeutic Solutions Aimed At Tissue Repair And Regenerationmediwound Is Recognized For Its Innovative Enzymatic Therapeuticsparticularly In Non Surgical Tissue Repairwhich Enhances Patient Outcomes And Reduces Healthcare Costs The Company Offers Several Productsincluding Nexobrida Biopharmaceutical Approved For The Removal Of Eschar In Burn Patientsescharex Is In Development For Chronic And Hard To Heal Woundswhile Mw005 Is A Candidate For Treating Non Melanoma Skin Cancersmediwound Operates A Cgmp Certified Manufacturing Facility And Is Expanding Its Production Capabilitiesthe Company Has Established Partnerships For Product Distributionincluding Collaborations With Vericel Corporation In The U Sand Kaken In Japanshowcasing Its Global Reach And Commitment To Innovation In Wound Healing
No conferences found for this company.
| Company Name | Mediwound Ltd |
| Country |
Israel
|
| Address | 42 Hayarkon Street Yavne Israel 8122745 |
| Telephone | Login to View |
| Login to View |
